Sodium transport across erythrocyte membranes in diabetes mellitus. 1986

P E Jennings, and M R Wilkins, and M J West, and M J Kendall, and A H Barnett

The activity of the erythrocyte ouabain sensitive Na/K ATPase pump was studied in 20 Type 1 diabetics, 15 Type 2 diabetics and 20 healthy controls. All diabetics were normotensive, caucasian and non-obese diabetics. The diabetics were assessed for retinopathy and had HbA1 estimated. The erythrocyte sodium concentration, membrane permeability to sodium and ouabain-sensitive sodium efflux rate constant (ERCos) were determined. The Type 1 diabetics had a significantly reduced ERC, mean +/- SD 0.198 +/- 0.028 hr-1 vs control 0.264 +/- 0.054 hr-1 (p less than 0.001). A similar reduction in ERCos was seen in the Type 2 diabetics when compared to controls (0.229 +/- 0.059 hr-1 p less than 0.005). There was also a significant difference between the 2 groups of diabetics (p less than 0.05). There was no significant difference in intracellular sodium concentrations. Membrane permeability was reduced in the Type 1 diabetics (3.69 +/- 0.79 mmol/kg dry wt/hr) compared to the control group (4.56 +/- 0.79 mmol/kg dry wt/hr, p less than 0.01). Diabetic control (HbA1) was positively correlated with ERCos, but no significant differences were seen in the ERCos between complicated and uncomplicated Type 1 diabetics. In vitro studies of normal erythrocytes did not show an effect on pump activity of increasing glucose or insulin concentration during a preincubation study. These results demonstrate that there is a reduction in activity of the ouabain-sensitive Na/K ATPase pump and a reduction in membrane permeability on the diabetic erythrocyte which is most marked in Type 1 diabetics.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010042 Ouabain A cardioactive glycoside consisting of rhamnose and ouabagenin, obtained from the seeds of Strophanthus gratus and other plants of the Apocynaceae; used like DIGITALIS. It is commonly used in cell biological studies as an inhibitor of the NA(+)-K(+)-EXCHANGING ATPASE. Acocantherin,G-Strophanthin,Acolongifloroside K,G Strophanthin
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D004910 Erythrocyte Membrane The semi-permeable outer structure of a red blood cell. It is known as a red cell 'ghost' after HEMOLYSIS. Erythrocyte Ghost,Red Cell Cytoskeleton,Red Cell Ghost,Erythrocyte Cytoskeleton,Cytoskeleton, Erythrocyte,Cytoskeleton, Red Cell,Erythrocyte Cytoskeletons,Erythrocyte Ghosts,Erythrocyte Membranes,Ghost, Erythrocyte,Ghost, Red Cell,Membrane, Erythrocyte,Red Cell Cytoskeletons,Red Cell Ghosts
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000254 Sodium-Potassium-Exchanging ATPase An enzyme that catalyzes the active transport system of sodium and potassium ions across the cell wall. Sodium and potassium ions are closely coupled with membrane ATPase which undergoes phosphorylation and dephosphorylation, thereby providing energy for transport of these ions against concentration gradients. ATPase, Sodium, Potassium,Adenosinetriphosphatase, Sodium, Potassium,Na(+)-K(+)-Exchanging ATPase,Na(+)-K(+)-Transporting ATPase,Potassium Pump,Sodium Pump,Sodium, Potassium ATPase,Sodium, Potassium Adenosinetriphosphatase,Sodium-Potassium Pump,Adenosine Triphosphatase, Sodium, Potassium,Na(+) K(+)-Transporting ATPase,Sodium, Potassium Adenosine Triphosphatase,ATPase Sodium, Potassium,ATPase, Sodium-Potassium-Exchanging,Adenosinetriphosphatase Sodium, Potassium,Pump, Potassium,Pump, Sodium,Pump, Sodium-Potassium,Sodium Potassium Exchanging ATPase,Sodium Potassium Pump

Related Publications

P E Jennings, and M R Wilkins, and M J West, and M J Kendall, and A H Barnett
July 1998, Casopis lekaru ceskych,
P E Jennings, and M R Wilkins, and M J West, and M J Kendall, and A H Barnett
September 1971, Biochimica et biophysica acta,
P E Jennings, and M R Wilkins, and M J West, and M J Kendall, and A H Barnett
January 1991, Laboratornoe delo,
P E Jennings, and M R Wilkins, and M J West, and M J Kendall, and A H Barnett
March 1971, Experientia,
P E Jennings, and M R Wilkins, and M J West, and M J Kendall, and A H Barnett
February 1977, Journal of theoretical biology,
P E Jennings, and M R Wilkins, and M J West, and M J Kendall, and A H Barnett
September 2009, Translational research : the journal of laboratory and clinical medicine,
P E Jennings, and M R Wilkins, and M J West, and M J Kendall, and A H Barnett
March 1996, Diabetes research and clinical practice,
P E Jennings, and M R Wilkins, and M J West, and M J Kendall, and A H Barnett
January 1966, The Scientific basis of medicine annual reviews,
P E Jennings, and M R Wilkins, and M J West, and M J Kendall, and A H Barnett
April 2005, Pakistan journal of pharmaceutical sciences,
P E Jennings, and M R Wilkins, and M J West, and M J Kendall, and A H Barnett
August 1988, FEBS letters,
Copied contents to your clipboard!